2,6-二氯咪唑并[1,2-b]吡嗪 | 112581-77-8

• 物质功能分类: 医药中间体 - 哒嗪类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 2,6-二氯咪唑并[1,2-b]吡嗪
• 中文别名: 2,6-二氯咪唑并[1,2-B]哒嗪；2,6-二氯咪唑并1,2-B哒嗪
• 英文名称: 2,6-Dichloroimidazo[1,2-b]pyridazine
• 英文别名: 2,6-dichloro-imidazol[1,2-b]pyridazine
• CAS: 112581-77-8
• 化学式: C₆H₃Cl₂N₃
• mdl: MFCD11044765
• 分子量: 188.016
• InChiKey: MGNCSIAIZSTMHX-UHFFFAOYSA-N

物化性质

• 密度：
  1.69

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  30.2
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090
• 储存条件：
  存储条件：2-8℃，请密闭保存并保持干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2,6-Dichloroimidazo[1,2-b]pyridazine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2,6-Dichloroimidazo[1,2-b]pyridazine
CAS number: 112581-77-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H3Cl2N3
Molecular weight: 188.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2,6-二氯咪唑并[1,2-b]吡嗪 生成 2-Chloroimidazo[1,2-b]pyridazine-3-sulfonyl chloride
  参考文献：
  名称：

  LABA, V. I.;SVIRIDOVA, A. V.;LITVINOV, V. P., TEZ. DOKL. 4 BCEC. KONF. XZHMIYA, FARMAKOL. I MEXANIZMY DEJSTVIYA PROTIVO+

  摘要：

  DOI：
• 作为产物：
  描述：

  1-(2,6-dichloroimidazo[1,2-b]pyridazin-3-yl)sulfonyl-3-(4,6-dimethylpyrimidin-2-yl)urea 生成 2,6-二氯咪唑并[1,2-b]吡嗪
  参考文献：
  名称：

  ISIDA, YASUO;OTA, KADZUNARI;NAKAXAMA, MATSUO;JOSIKAVA, XARUTOSI

  摘要：

  DOI：
• 作为试剂：
  描述：

  2,6-二氯咪唑并[1,2-b]吡嗪 、 1,3-双(二苯基膦)丙烷 、 、 丙基溴化镁 、 硫酸 在 镍 、 环烷酸镍 氮 、 2,6-二氯咪唑并[1,2-b]吡嗪 、 邻二甲苯 、 水 作用下， 以 四氢呋喃 、 邻二甲苯 、 甲苯 为溶剂， 反应 2.0h， 以to obtain 20.9 g of 6-n-propyl-2-chloroimidazo[1,2-b]pyridazine (purity: 93.2%)的产率得到2-chloro-6-n-propylimidazo[1,2-b]pyridazine
  参考文献：
  名称：

  Process for producing sulfonyl chloride compound

  摘要：

  一种生产磺酰氯化合物的方法，包括：（A）步骤，其中反应式（1）所表示的吡嗪化合物与磺化试剂反应，其中R1表示氢原子、卤原子、可以用卤原子或原子替换的烷基或类似物，R2和R3相同或不同，各自表示氢原子或类似物，R4表示氢原子、卤原子、可以用卤原子或原子替换的烷基或类似物；（B）步骤，其中将步骤（A）中得到的反应混合物与氯化试剂接触；以及（C）步骤，其中将步骤（B）中得到的反应混合物与无机碱性水溶液混合，以分离出含有反式（2）所表示的磺酰氯化合物的有机层，其中R1至R4的含义如上所定义。

  公开号：

  US08148524B2

文献信息

• [EN] TRIAZOLO COMPOUNDS<br/>[FR] COMPOSÉS TRIAZOLO
  申请人：HOFFMANN LA ROCHE

  公开号：WO2014072261A1

  公开（公告）日：2014-05-15

  The present invention relates to compounds of formula (I) and its use for the treatment of neurological disorders.

  本发明涉及式(I)的化合物及其在治疗神经系统疾病中的应用。
• [EN] HETEROARYL COMPOUNDS AS PIKK INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROARYLE EN TANT QU'INHIBITEURS DES PIKK
  申请人：AMGEN INC

  公开号：WO2010132598A1

  公开（公告）日：2010-11-18

  The present invention provides compounds that are PIKK inhibitors, more specifically, mTOR and/or PI3Kα kinase inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of kinases, specifically PI3 kinases, more specifically, mTOR and/or PI3Kα, such as cancer. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.

  本发明提供了一种PIKK抑制剂化合物，更具体地说，是mTOR和/或PI3Kα激酶抑制剂，因此适用于治疗通过抑制激酶可治疗的疾病，具体而言是PI3激酶，更具体地说是mTOR和/或PI3Kα，如癌症。还提供了含有这种化合物的药物组合物和制备这种化合物的方法。
• Imidazopyridazines and use as antiasthmatic agents
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05155108A1

  公开（公告）日：1992-10-13

  The imidazo[1,2-b]pyridazine compounds of the formula: ##STR1## wherein R.sub.1 is a hydrogen or halogen atom, or a lower alkyl group optionally having substituent(s), R.sub.2 an R.sub.3 are, independently, a hydrogen atom, a lower alkyl group optionally having substituent(s), a cycloalkyl group or a phenyl group optionally having substituent(s) or R.sub.2 and R.sub.3 together with the adjacent nitrogen atom to which they bond may form a heterocyclic ring optionally having substituent(s), X is an oxygen atom or S(O)n (n=0 to 2), Alk is a straight or branched chain alkylene group containing 1-10 carbon atoms and optionally having substituent(s), or their pharmaceutically acceptable salts which possess antiallergic, anti-inflammatory and anti-PAF activities, and their production and use.

  式中imidazo [1,2-b] pyridazine化合物：##STR1## 其中R.sub.1是氢原子或卤素原子，或是具有取代基的低烷基，R.sub.2和R.sub.3分别是氢原子，具有取代基的低烷基，环烷基或苯基，或者R.sub.2和R.sub.3与它们键合的相邻氮原子一起可以形成具有取代基的杂环，X是氧原子或S（O）n（n = 0至2），Alk是含有1-10个碳原子的直链或支链烷基，也可以具有取代基，或其药学上可接受的盐，具有抗过敏，抗炎和抗PAF活性，以及其生产和使用。
• Imidazopyridazines
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05202324A1

  公开（公告）日：1993-04-13

  The imidazo[1,2-b]pyridazine compounds of the formula: ##STR1## wherein R.sub.1 is a hydrogen or halogen atom, or a lower alkyl group optionally having substituent(s), R.sub.2 and R.sub.3 are, independently, a hydrogen atom, a lower alkyl group optionally having substituent(s), a cycloalkyl group or a phenyl group optionally having substituent(s) or R.sub.2 and R.sub.3 together with the adjacent nitrogen atom to which they bond may form a heterocyclic ring optionally having substituent(s), X is an oxygen atom or S(O).sub.n (n=0 to 2), Alk is a straight or branched chain alkylene group containing 1-10 carbon atoms and optionally having substituent(s), or their pharmaceutically acceptable salts which possess antiallergic, anti-inflammatory and anti-PAF activities, and their production and use.

  式为：##STR1##的咪唑并[1,2-b]吡嗪化合物，其中R.sub.1是氢原子或卤素原子，或是具有取代基的低碳基，R.sub.2和R.sub.3是独立的氢原子，具有取代基的低碳基，环烷基或苯基，或R.sub.2和R.sub.3与它们所键合的相邻氮原子一起可以形成具有取代基的杂环，X是氧原子或S(O).sub.n（n = 0到2），Alk是含有1-10个碳原子的直链或支链烷基，并且可以具有取代基，或其药学上可接受的盐，具有抗过敏，抗炎和抗PAF活性，以及它们的生产和使用。
• Novel process for producting imidazo[1,2-b]pyridazine derivative
  申请人：Tabuchi Takanori

  公开号：US20050171108A1

  公开（公告）日：2005-08-04

  A process for easily and inexpensively producing an imidazo[1,2-b]pyridazin-3-ylsulfonamide derivative which has a substituent bonded to the 6-position carbon atom and is represented by the formula (II): (wherein R represents lower alkyl, lower cycloalkyl optionally substituted by lower alkyl, lower alkenyl, or lower alkynyl), the process comprising reacting an imidazo[1,2-b]pyridazine compound represented by the formula (I): (wherein X represents halogeno or lower alkyl optionally substituted by halogeno; Y represents hydrogen or SO 2 N═CH—NR 1 R 2 ; and Z represents halogeno or OSO 2 R 3 ) with an organometallic compound in the presence of a transition metal catalyst. The derivative is useful as an intermediate for herbicides.

  一种用于简便、低成本地生产具有取代基与6-位碳原子键合的咪唑[1,2-b]吡嗪-3-基磺酰胺衍生物的方法，其化学式表示为(II):(其中R代表低烷基、低环烷基(可选地被低烷基取代)、低烯基或低炔基)，该方法包括在过渡金属催化剂的存在下，将咪唑[1,2-b]吡嗪化合物与有机金属化合物反应，所述咪唑[1,2-b]吡嗪化合物的化学式表示为(I):(其中X代表卤素或低烷基(可选地被卤素取代)；Y代表氢或SO2N═CH—NR1R2；Z代表卤素或OSO2R3)。该衍生物可用作除草剂的中间体。